PubMed:10443228
Annnotations
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 400-405 | HP_0002664 | denotes | tumor |
| T2 | 439-452 | HP_0003002 | denotes | breast cancer |
| T3 | 439-452 | HP_0100013 | denotes | breast cancer |
| T4 | 446-452 | HP_0002664 | denotes | cancer |
| T5 | 601-606 | HP_0002664 | denotes | tumor |
| T6 | 978-991 | HP_0003002 | denotes | breast cancer |
| T7 | 978-991 | HP_0100013 | denotes | breast cancer |
| T8 | 985-991 | HP_0002664 | denotes | cancer |
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 209-224 | protein | denotes | HDL-cholesterol |
| T2 | 240-257 | protein | denotes | beta-lipoproteins |
| T3 | 307-311 | protein | denotes | SHBG |
| T4 | 313-315 | protein | denotes | T3 |
| T5 | 317-319 | protein | denotes | T4 |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C13 | 138-147 | NP | denotes | body mass |
| C6 | 155-163 | NP | denotes | body fat |
| C4 | 170-179 | NP | denotes | body mass |
| C17 | 439-452 | NP | denotes | breast cancer |
| C1 | 573-597 | NP | denotes | lymphocytic infiltration |
| C3 | 722-731 | NP | denotes | body mass |
| C5 | 736-739 | NP | denotes | fat |
| C7 | 793-802 | NP | denotes | body mass |
| C8 | 807-811 | NP | denotes | fat; |
| C12 | 831-855 | NP | denotes | lymphocytic infiltration |
| C18 | 978-991 | NP | denotes | breast cancer |
| R1 | C4 | C13 | coref-ident | body mass,body mass |
| R2 | C3 | C4 | coref-ident | body mass,body mass |
| R3 | C5 | C6 | coref-ident | fat,body fat |
| R4 | C7 | C3 | coref-ident | body mass,body mass |
| R5 | C8 | C5 | coref-ident | fat;,fat |
| R6 | C12 | C1 | coref-ident | lymphocytic infiltration,lymphocytic infiltration |
| R7 | C18 | C17 | coref-ident | breast cancer,breast cancer |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-123 | Sentence | denotes | [Hormonal metabolic status in breast cancer patients after conservative surgery: comparison with known prognostic criteria] |
| S2 | 125-485 | Sentence | denotes | Body weight, body mass index, body fat, lean body mass, blood-glucose, cholesterol, HDL-cholesterol, triglyceride, beta-lipoproteins, insulin, gonadotropin, estradiol, testosterone, SHBG, T3, T4 and TSH levels as well as estradiol and progesterone receptor levels in excised tumor were studied in 40 patients with breast cancer prior to conservative treatment. |
| S3 | 486-639 | Sentence | denotes | Said anthropometric, metabolic and hormonal parameters were compared with the index of lymphocytic infiltration of tumor selected as a prognostic factor. |
| S4 | 640-755 | Sentence | denotes | A significant correlation between high lymphocytic infiltration (2.5 points), low body mass and fat was identified. |
| S5 | 756-864 | Sentence | denotes | Also, smoking contributed to loss of body mass and fat; however, it caused lymphocytic infiltration to rise. |
| S6 | 865-1008 | Sentence | denotes | Moderate body mass, relatively low fat level and positive receptor status are among factors of good prognosis in breast cancer of early stages. |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 1-26 | other_name | denotes | Hormonal metabolic status |
| T2 | 30-52 | multi_cell | denotes | breast cancer patients |
| T3 | 59-79 | other_name | denotes | conservative surgery |
| T4 | 125-136 | other_name | denotes | Body weight |
| T5 | 138-153 | other_name | denotes | body mass index |
| T6 | 155-163 | other_name | denotes | body fat |
| T7 | 165-179 | other_name | denotes | lean body mass |
| T8 | 181-194 | carbohydrate | denotes | blood-glucose |
| T9 | 196-207 | lipid | denotes | cholesterol |
| T10 | 209-224 | protein_complex | denotes | HDL-cholesterol |
| T11 | 226-238 | carbohydrate | denotes | triglyceride |
| T12 | 240-257 | protein_family_or_group | denotes | beta-lipoproteins |
| T13 | 259-266 | peptide | denotes | insulin |
| T14 | 268-280 | peptide | denotes | gonadotropin |
| T15 | 282-291 | lipid | denotes | estradiol |
| T16 | 293-305 | lipid | denotes | testosterone |
| T17 | 307-311 | protein_molecule | denotes | SHBG |
| T18 | 313-315 | protein_molecule | denotes | T3 |
| T19 | 317-319 | protein_molecule | denotes | T4 |
| T20 | 324-327 | peptide | denotes | TSH |
| T21 | 392-405 | other_name | denotes | excised tumor |
| T22 | 425-433 | multi_cell | denotes | patients |
| T23 | 439-452 | other_name | denotes | breast cancer |
| T24 | 462-484 | other_name | denotes | conservative treatment |
| T25 | 521-540 | other_name | denotes | hormonal parameters |
| T26 | 573-597 | other_name | denotes | lymphocytic infiltration |
| T27 | 601-606 | tissue | denotes | tumor |
| T28 | 621-638 | other_name | denotes | prognostic factor |
| T29 | 679-703 | other_name | denotes | lymphocytic infiltration |
| T30 | 718-731 | other_name | denotes | low body mass |
| T31 | 736-739 | lipid | denotes | fat |
| T32 | 793-802 | other_name | denotes | body mass |
| T33 | 807-810 | lipid | denotes | fat |
| T34 | 831-855 | other_name | denotes | lymphocytic infiltration |
| T35 | 874-883 | other_name | denotes | body mass |
| T36 | 896-899 | other_name | denotes | low |
| T37 | 900-903 | lipid | denotes | fat |
| T38 | 978-991 | other_name | denotes | breast cancer |
| T39 | 995-1007 | other_name | denotes | early stages |